Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited has announced an update regarding its ongoing on-market buy-back program. As of November 26, 2025, the company has repurchased a total of 425,624 ordinary fully paid securities, including 72,199 securities bought back on the previous day. This buy-back initiative is part of Nanosonics’ strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:NAN) stock is a Hold with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company is known for its innovative products that focus on reducing the risk of infection transmission in medical settings.
Average Trading Volume: 703,625
Technical Sentiment Signal: Sell
Current Market Cap: A$1.24B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.